Adenoviral vectors for treating disease

Details for Australian Patent Application No. 2005209653 (hide)

Owner Onyx Pharmaceuticals, Inc.

Inventors Johnson, Leisa; Hermiston, Terry; Hawkins, Lynda K.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005209653

Parent 781775

Filing date 9 September 2005

Wipo publication date 6 October 2005

Acceptance publication date 1 March 2007

International Classifications

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 15/28 (2006.01) Mutation or genetic engineering

C12N 15/55 (2006.01) Mutation or genetic engineering - Hydrolases (3)

Event Publications

29 September 2005 Complete Application Filed

6 October 2005 Application Open to Public Inspection

  Published as AU-B-2005209653

1 March 2007 Application Accepted

  Published as AU-B-2005209653

28 June 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005209654-Manufactured seed having a live end seal

2005209652-Ladder guard